相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Diagnosis and Treatment of Parkinson Disease A Review
Melissa J. Armstrong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Personalized prediction of depression in patients with newly diagnosed Parkinson's disease: A prospective cohort study
Si-Chun Gu et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
MAP/ERK Signaling in Developing Cognitive and Emotional Function and Its Effect on Pathological and Neurodegenerative Processes
Hector Albert-Gasco et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Vascular risk factors and depression in Parkinson's disease
R. Ou et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Zishenpingchan granules for the treatment of Parkinson's disease: a randomized, double-blind, placebo-controlled clinical trial
Qing Ye et al.
NEURAL REGENERATION RESEARCH (2018)
Understanding the DSM-5: stasis and change
Rachel Cooper
HISTORY OF PSYCHIATRY (2018)
Non-motor features of Parkinson disease
Anthony H. V. Schapira et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Chronic mild stress augments MPTP induced neurotoxicity in a murine model of Parkinson's disease
Udaiyappan Janakiraman et al.
PHYSIOLOGY & BEHAVIOR (2017)
Anti-apoptotic effect of Shudipingchan granule in the substantia nigra of rat models of Parkinson's disease
Qing Ye et al.
NEURAL REGENERATION RESEARCH (2016)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson's disease
Atami Sagna et al.
PARKINSONISM & RELATED DISORDERS (2014)
Modeling depression in Parkinson disease Disease-specific and nonspecific risk factors
Albert F. G. Leentjens et al.
NEUROLOGY (2013)
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
I. H. Richard et al.
NEUROLOGY (2012)
Anxiety Rating Scales in Parkinson's Disease: A Validation Study of the Hamilton Anxiety Rating Scale, the Beck Anxiety Inventory, and the Hospital Anxiety and Depression Scale
Albert F. G. Leentjens et al.
MOVEMENT DISORDERS (2011)
Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Paolo Barone et al.
LANCET NEUROLOGY (2010)
Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease
Claire L. Tomlinson et al.
MOVEMENT DISORDERS (2010)
A controlled trial of antidepressants in patients with Parkinson disease and depression
M. Menza et al.
NEUROLOGY (2009)
Sustained Administration of Pramipexole Modifies the Spontaneous Firing of Dopamine, Norepinephrine, and Serotonin Neurons in the Rat Brain
O. Chernoloz et al.
NEUROPSYCHOPHARMACOLOGY (2009)
A comprehensive review of the placebo effect: Recent advances and current thought
Donald D. Price et al.
ANNUAL REVIEW OF PSYCHOLOGY (2008)
Comparison of desipramine and citalopram treatments for depression in Parkinson's disease:: A double-blind, randomized, placebo-controlled study
David Devos et al.
MOVEMENT DISORDERS (2008)
A systematic review of prevalence studies of depression in Parkinson's disease
Jennifer S. A. M. Reijnders et al.
MOVEMENT DISORDERS (2008)
Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models
Kristopher J. Preacher et al.
BEHAVIOR RESEARCH METHODS (2008)
The impact of depressive symptoms in early Parkinson disease
B. Ravina et al.
NEUROLOGY (2007)
Depression rating scales in Parkinson's disease: Critique and recommendations
Anette Schrag et al.
MOVEMENT DISORDERS (2007)
Provisional diagnostic criteria for depression in Parkinson's disease: Report of an NINDS/NIMH work group
L Marsh et al.
MOVEMENT DISORDERS (2006)
Neurobiological mechanisms of the placebo effect
F Benedetti et al.
JOURNAL OF NEUROSCIENCE (2005)
The Parkinson's disease sleep scale:: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease
KR Chaudhuri et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
Expectation and dopamine release:: Mechanism of the placebo effect in Parkinson's disease
R de la Fuente-Fernández et al.
SCIENCE (2001)
Parkinson's disease subtypes: clinical classification and ventricular cerebrospinal fluid analysis
MC Schiess et al.
PARKINSONISM & RELATED DISORDERS (2000)
分享论文
